Vectorious Medical Technologies has raised cash to trial an implant for monitoring left atrial pressure in congestive heart failure patients, Globes reports. The series B round will fund a device the Israel-based company sees improving outcomes and cutting costs in an indication dogged by stubbornly high mortality rates.

Vectorious’ answer to the solidly double-digit one-year mortality rate of heart failure patients is a miniature implant. Following delivery via a minimally invasive procedure, the device gathers data on blood flow in the left atrium. The data are transmitted via what Vectorious describes as a “push button” system that incorporates an external home unit.

Link to Press Release